GINKGO BIOWORKS logo

GINKGO BIOWORKS

27 Drydock Avenue, 8th floor, Boston, MA 02210, United States
Ginkgo Bioworks, Inc specifies their major offering areas as: Biological Engineering, Metabolic Engineering, GMOS, Strain Engineering, DNA Synthesis, and Fermentation.
DUNS #:
827811626
CAGE Code:
563U7
Type:
Services Provider
Employees:
200-500
Annual Revenue:
$5M-$50M
Year Founded:
2009
Country of Origin:
United States
Sectors Served:
US Federal
Company Security Level:
Unknown
Credit Card Usage:
No

Specialties and Expertise:

Alternative Medicine, Biopharma, Biotechnology, Chemical Engineering, Health Care, Life Science, Biological Engineering, Metabolic Engineering, Strain Improvement, Industrial Fermentation, Strain G...

Contact/Location Info4

Size and minority status

Size
Other than small business
Ownership
African American
Alaska Native
Asian-Indian
Asian-Pacific
Hispanic
Minority-Unspecified
Native American
Native Hawaiian
Tribal
Unspecified
Veteran
Woman
Government Set-Aside Programs
AbilityOne
HUBZone
SBA 8(a)
SDVOSB
Small Disadvantaged Business (SDB)
Woman Owned Small Business (WOSB)

Commodity Codes10

PRODUCTS AND SERVICES2

Bioworks Foundries
1 past experience
Ginkgo has built Bioworks Foundries and Codebase to automate and scale the process of organism engineering, allowing engineers to prototype biological designs.
Cultured Ingredients
2 past experiences
Ginkgo is working to produce cultured cannabinoids and to construct strain that produces these cannabinoids.

Past experience7

SBIR
Adapting wireless glucometer to boost opioi...
DESCRIPTION: Plant-derived secondary metabolites have proven to be a rich source of pharmaceuticals. From 1981 to 2010, over 65% of...
SBIR
Controlling Antibiotic Resistance by Vaccin...
Next-generation sequencing technologies are allowing researchers to rapidly and accurately interrogate the genomic content of microb...
SBIR
SBIR Phase I: Bioproduction of Feedstock Am...
This Small Business Innovation Research (SBIR) Phase I project aims to produce microbes capable of cost-effective production of amin...
SBIR
SBIR Phase I: Volatile gene expression repo...
This Small Business Innovation Research Phase I project proposes to develop a set of novel, versatile measurement tools for use duri...
My Notes
Contact
My Notes